BUSINESS / MARKETS / POLITICS8 November 2026
← Story archive

Business

How Cardiologists’ High Hopes for Two Drugs Were Dashed

NYT BusinessSubscription may apply

By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?

Read original reporting ↗

Follow the evidence

Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.

Coverage timeline

Published reporting in time order

No additional matched coverage has been archived for this story yet.

This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →